Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Non-Muscle Invasive Bladder Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lung Neoplasms 1Lower Urinary Tract Symptoms 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Metformin 12Clomiphene 6Inositol 3maltodextrin 2artenimol 2Thioctic Acid 2Tablets 2Sugars 2Spironolactone 2Pioglitazone 2Orlistat 2Contraceptives, Oral 2Cholecalciferol 2salicylsalicylic acid 1licogliflozin 1follitropin alfa 1elagolix 1Vitamin E 1Vitamin D 1Tooth Exfoliation 1Sodium Salicylate 1Root Planing 1Resveratrol 1Quercetin 1Pentoxifylline 1Ovulation Induction 1Linseed Oil 1Leuprolide 1Letrozole 1Inulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Polycystic Ovary Syndrome × Capsules × Clear all
NCT07182526 2025-09-19

Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome

Al-Mustansiriyah University

Phase 2 Recruiting
150 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡